Science

#Omicron COVID variant ‘dominant’ in France from start of 2022: PM

#Omicron COVID variant ‘dominant’ in France from start of 2022: PM

omicron variant
Credit: Pixabay/CC0 Public Domain

French Prime Minister Jean Castex on Friday likened the spread of the Omicron variant in Europe to “lightning”, adding that it would be the dominant strain in France from the start of 2022.

Castex added that while much remains unknown about the variant “it does not seem to be more dangerous than the Delta variant and the data available to us indicate that complete vaccination coverage with the booster dose protects well against severe forms of the disease”.

Nearly 3,000 people are in intensive care with COVID-19 in France according to latest figures.

Meanwhile eligibility for booster jabs will be reduced from five months from the date of the second vaccination to four, Castex added.

And he said the government would announce new measures to tackle non-vaccination from next year.

“While we have given time, a lot of time for those French people who were hesitant and had doubts, in January we will strengthen the incentive for vaccination, because it is not acceptable that the refusal of a few million French people to be vaccinated, puts the life of an entire country at risk,” he said.


France pushes vaccination campaign as virus cases increase


© 2021 AFP

Citation:
Omicron COVID variant ‘dominant’ in France from start of 2022: PM (2021, December 17)
retrieved 17 December 2021
from https://medicalxpress.com/news/2021-12-omicron-covid-variant-dominant-france.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

If you liked the article, do not forget to share it with your friends. Follow us on Google News too, click on the star and choose us from your favorites.

For forums sites go to Forum.BuradaBiliyorum.Com

If you want to read more Like this articles, you can visit our Science category.

Source

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close

Please allow ads on our site

Please consider supporting us by disabling your ad blocker!